Send comments and news tips to [email protected]. Cite this: Edited by Shrabasti Bhattacharya. Intensive Bevacizumab Boosts Vision in Macular Degeneration - Medscape - June 19, 2025.

Zentiva inks €220M deal to commercialize AstraZeneca GI cast-off in Europe By Darren Incorvaia May 22, 2025 1:30am Zentiva Licensing deals AstraZeneca gastroesophageal reflux disease (GERD) ...

The Food and Drug Administration (FDA) has approved Jobevne ™ (bevacizumab-nwgd), a biosimilar to Avastin ® (bevacizumab).

A new bevacizumab (Avastin) biosimilar, bevacizumab-nwgd (Jobevne), has been approved for the treatment of various cancers. Bevacizumab-nwgd offers a potentially more affordable treatment option. The ...

Atezolizumab and bevacizumab Atezolizumab and bevacizumab are cancer drugs. How to pronounce the drug names are in brackets: atezolizumab (a-teh-zoh-liz-yoo-mab) bevacizumab (bev-a-ciz-oo-mab) You ...

Zentiva now holds approx. 83.57% of the share capital and approx. 85.27% of the voting rights of APONTIS PHARMA. As announced on 27 November 2024, all offer conditions set out in the offer ...

Avastin (bevacizumab) is a brand-name infusion that’s prescribed for certain types of cancer. The cost of the drug with and without insurance can depend on several factors, such as whether ...

A total of 1,401 patients were randomly assigned in this 2 × 2 analysis. Median progression-free survival (PFS) was 9.4 months in the bevacizumab group and 8.0 months in the placebo group (hazard ...

Alymsys is supplied in single-dose vials containing 100mg/4mL and 400mg/16mL of bevacizumab-maly. Reference Amneal launches first biosimilar with Alymsys ® (bevacizumab-maly) in the United States.

First of three approved U.S. oncology biosimilars Amneal expects to launch Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today ...